Sahin AA - Search Results

1

Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity.

Li CW, Lim SO, Xia W, Lee HH, Chan LC, Kuo CW, Khoo KH, Chang SS, Cha JH, Kim T, Hsu JL, Wu Y, Hsu JM, Yamaguchi H, Ding Q, Wang Y, Yao J, Lee CC, Wu HJ, Sahin AA, Allison JP, Yu D, Hortobagyi GN, Hung MC. Li CW, et al. Among authors: sahin aa. Nat Commun. 2016 Aug 30;7:12632. doi: 10.1038/ncomms12632. Nat Commun. 2016. PMID: 27572267 Free PMC article.

2

Expression profile of tyrosine kinases in breast cancer.

Meric F, Lee WP, Sahin A, Zhang H, Kung HJ, Hung MC. Meric F, et al. Clin Cancer Res. 2002 Feb;8(2):361-7. Clin Cancer Res. 2002. PMID: 11839650

3

Her-2/neu gene amplification in ductal carcinoma in situ of the breast.

Hoque A, Sneige N, Sahin AA, Menter DG, Bacus JW, Hortobagyi GN, Lippman SM. Hoque A, et al. Among authors: sahin aa. Cancer Epidemiol Biomarkers Prev. 2002 Jun;11(6):587-90. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12050101

4

Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy.

Buchholz TA, Katz A, Strom EA, McNeese MD, Perkins GH, Hortobagyi GN, Thames HD, Kuerer HM, Singletary SE, Sahin AA, Hunt KK, Buzdar AU, Valero V, Sneige N, Tucker SL. Buchholz TA, et al. Among authors: sahin aa. Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):880-8. doi: 10.1016/s0360-3016(02)02850-x. Int J Radiat Oncol Biol Phys. 2002. PMID: 12095553

5

Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline-based neoadjuvant chemotherapy in patients with breast carcinoma.

Wang J, Buchholz TA, Middleton LP, Allred DC, Tucker SL, Kuerer HM, Esteva FJ, Hortobagyi GN, Sahin AA. Wang J, et al. Among authors: sahin aa. Cancer. 2002 Jun 15;94(12):3107-14. doi: 10.1002/cncr.10585. Cancer. 2002. PMID: 12115341 Free article.

6

A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm.

Kumar R, Wang RA, Mazumdar A, Talukder AH, Mandal M, Yang Z, Bagheri-Yarmand R, Sahin A, Hortobagyi G, Adam L, Barnes CJ, Vadlamudi RK. Kumar R, et al. Nature. 2002 Aug 8;418(6898):654-7. doi: 10.1038/nature00889. Nature. 2002. PMID: 12167865

7

Molecular prognostic factors for breast cancer metastasis and survival.

Esteva FJ, Sahin AA, Cristofanilli M, Arun B, Hortobagyi GN. Esteva FJ, et al. Among authors: sahin aa. Semin Radiat Oncol. 2002 Oct;12(4):319-28. doi: 10.1053/srao.2002.35251. Semin Radiat Oncol. 2002. PMID: 12382190 Review.

8

Global gene expression changes during neoadjuvant chemotherapy for human breast cancer.

Buchholz TA, Stivers DN, Stec J, Ayers M, Clark E, Bolt A, Sahin AA, Symmans WF, Hess KR, Kuerer HM, Valero V, Hortobagyi GN, Pusztai L. Buchholz TA, et al. Among authors: sahin aa. Cancer J. 2002 Nov-Dec;8(6):461-8. doi: 10.1097/00130404-200211000-00010. Cancer J. 2002. PMID: 12500855

9

Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy.

Buchholz TA, Davis DW, McConkey DJ, Symmans WF, Valero V, Jhingran A, Tucker SL, Pusztai L, Cristofanilli M, Esteva FJ, Hortobagyi GN, Sahin AA. Buchholz TA, et al. Among authors: sahin aa. Cancer J. 2003 Jan-Feb;9(1):33-41. doi: 10.1097/00130404-200301000-00007. Cancer J. 2003. PMID: 12602766

10

HER2 regulation of peroxisome proliferator-activated receptor gamma (PPARgamma) expression and sensitivity of breast cancer cells to PPARgamma ligand therapy.

Yang Z, Bagheri-Yarmand R, Balasenthil S, Hortobagyi G, Sahin AA, Barnes CJ, Kumar R. Yang Z, et al. Among authors: sahin aa. Clin Cancer Res. 2003 Aug 1;9(8):3198-203. Clin Cancer Res. 2003. PMID: 12912973

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

350 results

Search Page